期刊文献+

模拟构建人肝衰竭血清对体外培养肝细胞功能的影响

Effect of human hepatic failure serum on function of hepatocytes cultured in vitro:A simulation experiment
下载PDF
导出
摘要 背景:生物人工肝核心材料为肝细胞,其功能好坏直接影响临床效果。目的:模拟构建一种能够和肝衰竭血清对体外培养肝细胞具有相同生物学效应的组合物。方法:观察和对比模拟肝衰竭血清、人肝衰竭血清和体积分数10%胎牛血清对培养的CL-1细胞形态学和细胞活力的变化,检测CL-1细胞酶包括乳酸脱氢酶、谷丙转氨酶、谷草转氨酶及谷胱甘肽的分泌量。结果与结论:模拟肝衰竭血清和人肝衰竭血清对培养的CL-1细胞活力,乳酸脱氢酶、谷丙转氨酶、谷草转氨酶和谷胱甘肽的分泌量的影响差异无显著性意义(P>0.05),CL-1细胞的生长均受到抑制,体积分数10%胎牛血清细胞功能良好。结果提示,模拟肝衰竭血清组合物与人肝衰竭血清对CL-1细胞的生物学效应基本相同。 BACKGROUND:The key material of bioartificial liver is the hepatocytes,whose function directly affects the clinical results.OBJECTIVE:To simulate a composite with similar biological effects with hepatic failure serum on the hepatocytes function cultured in vitro.METHODS:The efficacy of the simulated serum liver failure,human liver failure serum and 10% fetal bovine serum on the cultured CL-1 cells was observed and compared,including cell morphology and cell viability,lactate dehydrogenase,aspartate aminotransferase,alanine aminotransferase and glutathione secretion.RESULTS AND CONCLUSION:The simulation liver failure and human liver failure serum had the same efficacy on CL-1 cell viability,lactate dehydrogenase,aspartate aminotransferase,alanine aminotransferase and glutathione secretion,with no significant difference (P0.05),CL-2 cell growth was inhibited,and CL-1 cells had good function state in 10% fetal bovine serum.The simulated liver failure serum and human liver failure serum have the same biological effect on CL-1 cells.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第51期9601-9604,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家高技术研究与发展计划(863计划)(2006AA02A141) 人源细胞混合性人工肝的研制与开发~~
  • 相关文献

参考文献12

  • 1Shi Q,Gaylor JD,Cousins R,et al.The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells.Artif Organs,1998;22(12):1023-1030.
  • 2Smirthwaite AD,Gaylor JD,Cousins RB,et al.Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes.Artif Organs.1998;22(10):831-836.
  • 3Hiromitsu N,Michiaki M,Makoto N,et al.Injuriousness of glycochenodeoxycholate and taurochenodeoxycholate to cultured hepatocytes.J Artif Organs.2002;5(9):30-36.
  • 4Ostrow JD,Pascolo L,Brites D,et al.Molecular basis of bilirubin-induced neurotoxicity.Trends Mol Med.2004;10(2):65-70.
  • 5Pazzi P,Morsiani E,Vilei MT,et al.Serum bile acids in patients with liver failure supported with a bioartificiaI liver.Aliment Pharmacol Ther.2002;16(8):1547-1554.
  • 6Carpentier B,Gautier A,Legallais C.Artificial and bioartificial liver devices:present and future.Gut.2009;58(12):1690-1702.
  • 7高森,郭颖,高毅.体外检测生物人工肝支持功能组合物的研制[J].广东医学,2010,31(6):694-696. 被引量:3
  • 8Nagaki M,Hughes RD,Keane HM,et al.In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines.Circ Shock.1992;38(3):182-188.
  • 9Boulton R,Woodman A,Calnan D,et al.Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and-1 beta:a mechanism of negative regulation of hepatocyte proliferation.Hepatology.1997;26(1):49-58.
  • 10Nieuwoudt M,Engelbrecht GH,Sentle L,et al.Non-toxicity of Ⅳ injected perfluorocarbon oxygen carrier in an animal model of liver regeneration following surgical injury.Artif Cells Blood Substit Immobil Biotechnol.2009;37(3):117-124.

二级参考文献12

  • 1陈钟,田鹏鹏,张鹤云,李根喜,丁义涛.一种新型生物人工肝系统的构建及体外功能评价[J].中国普通外科杂志,2004,13(8):598-601. 被引量:4
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 3FRUHAUF N R,OLDHAFER K J,HOLTJE M,et al.A bioartificial liver support system using primary hepatocytes:a preclinical study in a new porcine hepatectomy model[J].Surgery,2004,136(1):47-56.
  • 4LI L J,DU W B,ZHANG Y M,et al.Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs[J].J Hepatol,2006,44(2):317-324.
  • 5POYCK P P,PLESS G,HOEKSTRA R,et al.In vitro comparison of two bioartificial liver support systems:MELS Cell Module and AMC-BAL[J].Int J Artif Organs,2007,30(3):183-191.
  • 6VAN DE KERKHOVEA M P,HOEKSTRA R,VAN GULIK T M,et al.Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research[J].Biomaterials,2004,25(9):1613-1625.
  • 7OSTROW J D,CELIC L,MUKERJEE P.Molecular and micellar associations in the pH-dependent stable and metastable dissolution of unconjugated bilirubin by bile salts[J].Lipid Res,1988,29(3):335-348.
  • 8HIROMITSU N,MICHIAKI M,MAKOTO N,et al.Injuriousness of glycochenodeoxycholate and taurochenodeoxycholate to cultured hepatocytes[J].Artif Organs,2002,5(1):30-36.
  • 9MUNDT A,PUHL G,MULLER A,et al.A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support[J].Int J Artif Organs,2002,25(6):542-548.
  • 10ELLIS A J,HUGHES R D,WENDON J A,et al.Pilot controlled trial of the extracorporeal liver assist device in acute liver failure[J].Hepatology,1996,24(6):1446-1451.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部